Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution
21 janv. 2021 15h58 HE
|
Inspirata, Inc.
Tampa, Florida, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that pandemic-related regulatory flexibilities issued by the U.S....
Biotricity Submitted 510(k) U.S. FDA Filing for Biotres
05 janv. 2021 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a...
Biotricity Provides Quarter Update and Announces Continued Growth
01 sept. 2020 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its...
Biotricity Receives FDA clearance for Bioflux Software II System
04 août 2020 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k)...
Northeast Scientific Inc. Wins 510(k) for IVUS Catheter Reprocessing
23 juin 2020 11h38 HE
|
Northeast Scientific, Inc.
WATERBURY, Conn., June 23, 2020 (GLOBE NEWSWIRE) -- Northeast Scientific Inc., this week announced it has received FDA clearance for reprocessing the .014 Digital IVUS catheter. This is the second...
Biotricity Files a 510(k) Application for its Advanced ECG Analysis Software
13 févr. 2020 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k)...
Biotricity Completes Development of its ECG Patch Platform
04 déc. 2019 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed...
BioSig Technologies Issues Shareholder Letter
11 sept. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Sept. 11, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD) a medical device company developing a proprietary biomedical signal processing platform...
BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System
14 août 2018 08h07 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from...
Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device
18 déc. 2017 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric...